Bret M. Benton
Novartis (United States)(US)
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, Bacterial Genetics and Biotechnology, Bacterial biofilms and quorum sensing
Most-Cited Works
- → Telavancin, a Multifunctional Lipoglycopeptide, Disrupts both Cell Wall Synthesis and Cell Membrane Integrity in Methicillin-Resistant Staphylococcus aureus(2005)426 cited
- → Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II(2009)170 cited
- → Large-Scale Identification of Genes Required for Full Virulence ofStaphylococcus aureus(2004)112 cited
- → In Vitro Activity of Telavancin against Resistant Gram-Positive Bacteria(2008)97 cited
- → Comparative Surveillance Study of Telavancin Activity against Recently Collected Gram-Positive Clinical Isolates from across the United States(2008)88 cited
- → Intrapulmonary Distribution of Intravenous Telavancin in Healthy Subjects and Effect of Pulmonary Surfactant on In Vitro Activities of Telavancin and Other Antibiotics(2007)80 cited
- → A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus.(1994)80 cited
- → Signal-mediated import of bacteriophage T7 RNA polymerase into the Saccharomyces cerevisiae nucleus and specific transcription of target genes.(1990)75 cited
- → In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative(2008)61 cited
- → Cloning and Functional Characterization of an NAD + -Dependent DNA Ligase from Staphylococcus aureus(2001)51 cited